HAMLET Pharma releases further data from clinical study
At the end of July 2019, Hamlet Pharma announced the successful completion of the Phase I/II bladder cancer study. We now provide more detailed information about the study outcome.At the end of July 2019, Hamlet Pharma announced the successful completion of the Phase I/II bladder cancer study. We now provide more detailed information about the study outcome. Twenty patients were treated with Alpha1H and patients received 6 instillations during one month, followed by surgery to remove the tumor. A further visit was included to document the safety of Alpha1H. Another 20 patients received